Betahistin-SZ, tablets 24 mg 60 pcs

A drug that improves microcirculation of the labyrinth, used in the pathology of the vestibular apparatus. Betahistine acts mainly on histamine H₁– and H₃-receptors of the inner ear and vestibular nuclei of the CNS.

By direct agonist action on the H₁-receptors of the inner ear vessels, as well as indirectly through action on the H₃-receptors improves microcirculation and capillary permeability, normalizes endolymph pressure in the labyrinth and cochlea. At the same time betahistine increases blood flow in the basilar artery.

It has a pronounced central effect, being an inhibitor of H₃-receptors of the vestibular nerve nuclei. It improves conduction in neurons of vestibular nuclei at brainstem level.

The clinical manifestation of the above properties is reduction of the frequency and intensity of dizziness, reduction of tinnitus, improvement of hearing if it is reduced.

Indications

Dizziness, Meniere’s Disease, Cerebral Circulatory Disorders

• treatment and prevention of vestibular vertigo of various origins;

• Syndromes including vertigo and headache, tinnitus, progressive hearing loss, nausea and vomiting;

• Meniere’s disease or syndrome.

.

Active ingredient

Betahistine

Composition

1 tablet contains:

the active ingredient:

betahistine dihydrochloride 24 mg;

excipients:

Microcrystalline cellulose 229.5 mg;

Lactose (milk sugar) 71.25 mg;

citric acid 7.5 mg;

colloidal silicon dioxide (aerosil) 17.4 mg;

talc 5.25 mg;

magnesium stearate 3.6 mg;

sodium lauryl sulfate 7.5 mg;

Starch 1500 (pregelatinized starch) 9.0 mg.